(Q64957632)

1 July 2019

title

Primary angioplasty versus systemic thrombolysis in anterior myocardial infarction. (English)

1 reference

1 July 2019

1 reference

García E

1

1 reference

1 July 2019

Elízaga J

2

1 reference

1 July 2019

Pérez-Castellano N

3

1 reference

1 July 2019

Serrano JA

4

1 reference

1 July 2019

Soriano J

5

1 reference

1 July 2019

Abeytua M

6

1 reference

1 July 2019

Botas J

7

1 reference

1 July 2019

Rubio R

8

1 reference

1 July 2019

López de Sá E

9

1 reference

1 July 2019

López-Sendón JL

10

1 reference

1 July 2019

Delcán JL

11

1 reference

1 July 2019

language of work or name

English

0 references

publication date

1 March 1999

1 reference

1 July 2019

Journal of the American College of Cardiology

published in

1 reference

1 July 2019

volume

33

1 reference

1 July 2019

issue

3

1 reference

1 July 2019

page(s)

605-611

1 reference

1 July 2019

A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900644-5

7 January 2021

A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900644-5

7 January 2021

A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900644-5

7 January 2021

Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900644-5

7 January 2021

The importance of the determination of the myocardial area at risk in the evaluation of the outcome of acute myocardial infarction in patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900644-5

7 January 2021

Effect of infarct location on the in-hospital prognosis of patients with first transmural myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900644-5

7 January 2021

Prognostic significance of electrocardiographic site of infarction after correction for enzymatic size of infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900644-5

7 January 2021

Short-term risk stratification at admission based on simple clinical data in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900644-5

7 January 2021

Prognostic significance of location and type of myocardial infarction: independent adverse outcome associated with anterior location

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900644-5

7 January 2021

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900644-5

7 January 2021

Influence of collateral circulation on in-hospital death from anterior acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900644-5

7 January 2021

Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative overview (meta-analysis) of the randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900644-5

7 January 2021

Immediate coronary angioplasty versus intravenous streptokinase in acute myocardial infarction: left ventricular ejection fraction, hospital mortality and reinfarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900644-5

7 January 2021

Influence of acute myocardial infarction location on in-hospital and late outcome after primary percutaneous transluminal coronary angioplasty versus tissue plasminogen activator therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900644-5

7 January 2021

Operator volume and outcomes in 12,998 percutaneous coronary interventions. Northern New England Cardiovascular Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900644-5

7 January 2021

Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900644-5

7 January 2021

A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction. Myocardial Infarction Triage and Intervention Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900644-5

7 January 2021

Early and late results of coronary angioplasty without antecedent thrombolytic therapy for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900644-5

7 January 2021

Emergency coronary angioplasty for acute myocardial infarction. Results from a community hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900644-5

7 January 2021

Emergency percutaneous transluminal coronary angioplasty in acute myocardial infarction: a 3 year experience

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900644-5

7 January 2021

Improved thrombolysis in acute myocardial infarction with front-loaded administration of alteplase: results of the rt-PA-APSAC patency study (TAPS)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900644-5

7 January 2021

Randomized angiographic trial of recombinant tissue-type plasminogen activator (alteplase) in myocardial infarction. RAAMI Study Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900644-5

7 January 2021

The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900644-5

7 January 2021

Frequency of inclusion of patients with cardiogenic shock in trials of thrombolytic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900644-5

7 January 2021

Outcome of patients with acute myocardial infarction who are ineligible for thrombolytic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900644-5

7 January 2021

10.1016/S0735-1097(98)00644-5

Identifiers

DOI

1 reference

1 July 2019

1 reference

1 July 2019